Effect of FR167653, a Novel Inhibitor of Tumor Necrosis Factor-?? and Interleukin-1?? Synthesis on Lipopolysaccharide-Induced Hepatic Microvascular Dysfunction in Mice
The DOI matches its Crossref record.
Abstract
Tumor necrosis factor-alpha (TNFalpha) and interleukin-1 (IL-1) have been recognized as key proinflammatory mediators in the pathogenesis of lipopolysaccharide (LPS)-induced liver injury. In the present study we examined the effect of FR167653, a novel inhibitor of TNFalpha and IL-1 synthesis, on the hepatic microvascular response to LPS using in vivo microscopy. Significant hepatic microvascular responses comprising leukocyte adhesion to the sinusoidal wall and central venules and reduced sinusoidal perfusion appeared 2 and 4 h after LPS (0.1 mg/kg, i.v.) injection in male C3H/HeN mice (LPS sensitive) when compared with male C3H/HeJ mice (LPS resistant). The serum concentrations of TNFalpha at 1.5 h and IL-1beta at 4 h after injection of LPS, as determined by enzyme-linked immunosorbent assay, were significantly higher in C3H/HeN mice than in C3H/HeJ mice. Administration of murine TNFalpha or IL-1beta (10 microg/kg., i.v., respectively) in both C3H/HeN and C3H/HeJ mice elicited the hepatic microvascular responses that were similar to those produced by LPS injection in C3H/HeN mice. FR167653 (1 and 10 mg/kg, i.v., 0 and 2 h after LPS injection) significantly reduced leukocyte adhesion and restored sinusoidal perfusion in a dose-dependent manner in C3H/HeN mice 4 h after LPS injection. The levels of TNFalpha, IL-1beta, and alanine aminotransferase also were significantly lower in FR167653-treated endotoxemic C3H/HeN mice than those in vehicle-treated endotoxemic animals. The results suggest that the hepatic microvascular response to LPS is partly mediated by TNFalpha and IL-1beta, and that FR167653 prevents LPS-induced hepatic microcirculatory dysfunction by inhibiting the production of TNFalpha and IL-1beta.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Zhang, L., Li, H.-Z., Gong, X., Luo, F.-L., Wang, B., Hu, N., Wang, C.-D., Zhang, Z., & Wan, J.-Y. (2010) · Phytomedicine · doi:10.1016/j.phymed.2010.01.008 · Cited by 79
Accelerated prion disease pathogenesis in toll-like receptor 4 signaling-mutant mice.
Spinner, D. S., Cho, I. S., Park, S. Y., Kim, J. I., Meeker, H. C., Ye, X., LaFauci, G., Kerr, D. J., Flory, M. J., Kim, B. S., et al. (2008) · Journal of Virology · doi:10.1128/jvi.00522-08 · Cited by 57
“The negative consequences of TNF- and IL-1 generation, which result from TLR4 activation, might be counteracted without dampening prion infection-protective phagocyte activation by coadministering specific antagonists to neutralize these cytokines (4, 27, 39 ).”
BackgroundHuang, Y.-H., Yang, Y.-L., Tiao, M.-M., Kuo, H.-C., Huang, L.-T., & Chuang, J.-H. (2012) · Peptides · doi:10.1016/j.peptides.2012.03.032 · Cited by 29
Buss, N. A. P. S., Gavins, F. N. E., Cover, P. O., Terron, A., & Buckingham, J. C. (2015) · The FASEB Journal · doi:10.1096/fj.14-268375 · Cited by 23
Metadata
- Authors
- Matsumoto, Y., Ito, Y., Hayashi, I., Majima, M., Ishii, K.-I., Katagiri, H., & Kakita, A.
- Venue
- Shock
- Published
- 2002-05
- Volume
- 17
- Issue
- 5
- Pages
- 411-415
- ISSN
- 1073-2322 (ISSN-L)
- OpenAlex
- W2072007706
- Cited by
- 18
- References
- 0
- FWCI
- 0.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effect of FR167653, a Novel Inhibitor of Tumor Necrosis Factor-?? and Interleukin-1?? Synthesis on Lipopolysaccharide-Induced Hepatic Microvascular Dysfunction in Mice. https://app.cochat.ai/papers/10.1097/00024382-200205000-00012
- The paper
- Matsumoto, Y., Ito, Y., Hayashi, I., Majima, M., Ishii, K.-I., Katagiri, H., & Kakita, A. (2002). Effect of FR167653, a Novel Inhibitor of Tumor Necrosis Factor-?? and Interleukin-1?? Synthesis on Lipopolysaccharide-Induced Hepatic Microvascular Dysfunction in Mice. Shock. https://doi.org/10.1097/00024382-200205000-00012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.